Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335893 · ClinicalTrials.gov registry record · Phase 1
Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01335893: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT01335893 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335893, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.
Interventions
- DRUG Indocyanine Green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-12-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335893
The ClinicalTrials.gov registry entry for NCT01335893 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green is the first listed.
NCT01335893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335893 about?
NCT01335893 is a clinical study titled "Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green". Our specific aim is to determine if Indocyanine Green (ICG) administered intraoperatively and imaged using our camera will aid in the identification of a suspected lung nodule.
What is the current status of trial NCT01335893?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2011-05. Estimated completion is 2014-12-14.
What interventions are being tested in trial NCT01335893?
The interventions under investigation include: Indocyanine Green (DRUG).
Who is sponsoring clinical trial NCT01335893?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.